Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy

Overview of attention for article published in Drug Design, Development and Therapy, January 2017

Altmetric Badge

Mentioned by

twitter: 1 X user

reddit: 1 Redditor

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 48 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 13 publications that cite this research output.

13

The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.

Chapter 2 Anti-CD20 antibody treatment for B-cell malignancies

Book chapter (January 2024)

Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: A prospective real-world study in Chinese cohort

Preprint in Research Square (May 2023)

Therapeutic Approaches to Employ Monoclonal Antibody for Cancer Treatment

Book chapter (January 2021)